The health care giant cutting its full-year earnings and revenue projections, and it blamed currency effects for doing so. Last quarter's numbers did beat estimates, and J&J chief financial officer Joe Wolk spoke with our Anjalee Khemlani about what drove profits in the quarter.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,